CCL3 plays a crucial role in the pathophysiology of NAFLD by participating in the recruitment of neutrophils to sites of inflammation. Additionally, CCL3 contributes to cancer progression by binding to receptors that induce movement and infiltration of colorectal adenocarcinoma cells. Here, CCL3 is linked to metabolic dysfunction-associated steatotic liver disease.